輸液治療市場規模、佔有率、成長分析、按產品、適應症、治療方法、應用、最終用戶、地區 - 產業預測，2025 年至 2032 年

2023 年全球輸液治療市場規模價值為 444.5 億美元，預計將從 2024 年的 474.3 億美元成長到 2032 年的 796.8 億美元，預測期內（2025-2032 年）的複合年成長率為 6.7%。

受人口老化和慢性病發病率上升的推動，全球輸液治療市場正在經歷顯著成長。這種治療方法將液體和藥物直接輸送到血液中，提供快速有效的治療，特別是抗生素、化療和營養支持。對患者來說，其好處在於劑量精準、療效延長、所需劑量減少、並且能夠在門診或家中進行治療。儘管輸液療法有其好處，但它也存在風險，包括感染和副作用，並且需要熟練的管理。輸液設備的技術進步和家庭醫療保健需求的不斷成長對於推動市場擴張至關重要。總體而言，輸液治療市場仍保持成長勢頭，滿足日益成長的高效醫療保健解決方案的需求。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

輸液治療市場規模（按產品）

• 市場概況
• 點滴幫浦
  • 攜帶式輸液泵
  • 固定輸液幫浦
  • 注射輸液幫浦
  • 一次性泵浦
  • 大容量泵
  • 合成橡膠泵
• 點滴器
• 配件

輸液治療市場規模（依適應症分類）

• 市場概況
• 癌症
• 消化系統疾病/紊亂
• 鬱血性心臟衰竭衰竭
• 類風濕性關節炎
• 血友病
• 免疫力缺乏
• 其他

輸液治療市場規模（依治療方法）

• 市場概況
• 抗生素/抗病毒藥物
• 抗凝血劑
• 止吐藥
• 血液成分刺激因子
• 化療
• 營養
• 補水
• 疼痛管理

輸液治療市場規模（按應用）

• 市場概況
• 化療
• 糖尿病
• 消化系統疾病
• 疼痛管理
• 其他

輸液治療市場規模（按最終用戶分類）

• 市場概況
• 醫院
• 門診手術中心
• 診所
• 居家護理設施

輸液治療市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Option Care Health Inc.（United States）
• Baxter International Inc.（United States）
• ICU Medical, Inc.（United States）
• B. Braun Melsungen AG（Germany）
• Terumo Corporation（Japan）
• Moog Inc.（United States）
• Fresenius SE & Co. KGaA（Germany）
• Smiths Medical（United Kingdom）
• JMS Co. Ltd.（Japan）
• Caesarea Medical Electronics（Israel）
• CareFusion Corporation（United States）
• Poly Medicure Limited（India）
• Nipro Corporation（Japan）
• Medtronic plc（Ireland）
• Becton, Dickinson and Company（BD）（United States）
• 3M Company（United States）
• Teleflex Incorporated（United States）
• Edwards Lifesciences Corporation（United States）
• Coloplast A/S（Denmark）
• Convatec Group plc（United Kingdom）

結論和建議

Global Infusion Therapy Market size was valued at USD 44.45 billion in 2023 and is poised to grow from USD 47.43 billion in 2024 to USD 79.68 billion by 2032, growing at a CAGR of 6.7% during the forecast period (2025-2032).

The global infusion therapy market is witnessing substantial growth, fueled by an aging population and the rising prevalence of chronic diseases. This therapy, which involves the direct delivery of fluids and medications into the bloodstream, provides rapid and effective treatment, particularly for antibiotics, chemotherapy, and nutritional support. Patients benefit from precise dosing and prolonged medication effects, reducing the frequency of administration and enabling outpatient or home treatment options. Despite its advantages, infusion therapy presents risks, including infection and side effects, necessitating skilled administration. Technological advancements in infusion devices and the growing demand for home healthcare are pivotal in driving market expansion. Overall, the infusion therapy market remains poised for growth, addressing the increasing needs for efficient healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infusion Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infusion Therapy Market Segmental Analysis

Global Infusion Therapy Market is segmented by Product, Indication, Therapy, Application, End-user and region. Based on Product, the market is segmented into Infusion Pumps, Infusion Set and Accessories. Based on Indication, the market is segmented into Cancer, Gastrointestinal Diseases/Disorders, Congestive Heart Failure, Rheumatoid Arthritis, Hemophilia, Immune Deficiencies and Others. Based on Therapy, the market is segmented into Antibiotic/Antiviral, Anti-coagulation, Anti-emetics, Blood Component Stimulating Factor, Chemotherapy, Nutrition, Hydration and Pain Management. Based on Application, the market is segmented into Chemotherapy, Diabetes, Gastrointestinal Diseases, Pain management and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Homecare Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infusion Therapy Market

The global infusion therapy market is significantly driven by the rising incidence of chronic illnesses, including cancer, diabetes, and cardiovascular diseases. As these health conditions continue to affect a larger portion of the population, the need for effective treatment options, particularly in the form of infusion therapy products and services, has surged. This growing demand is prompting healthcare providers to expand their infusion therapy offerings, leading to innovations and advancements in technology that enhance patient care. Consequently, the infusion therapy market is experiencing robust growth, fueled by the increasing requirements for targeted and effective treatment strategies for chronic disease management.

Restraints in the Global Infusion Therapy Market

The Global Infusion Therapy market faces significant constraints, primarily due to the elevated expenses linked to infusion therapy products and services. This financial burden poses a major challenge, particularly in developing nations where healthcare access is already restricted. The high costs can limit the adoption and utilization of essential infusion therapies, hindering patient care and overall market growth. As a result, many potential users may be unable to afford the necessary treatments, further exacerbating healthcare inequities and limiting the market's expansion in regions that most require these critical services. Addressing these financial barriers is essential for market advancement.

Market Trends of the Global Infusion Therapy Market

The Global Infusion Therapy market is experiencing a notable shift towards home infusion therapy, driven by an increasing preference among patients for home-based healthcare services. This trend reflects a desire for enhanced convenience, comfort, and cost-efficiency, as patients seek to avoid the hospital environment whenever possible. As a result, healthcare providers are adapting to this demand by offering advanced home infusion solutions, empowering patients with autonomy over their treatment while reducing hospital congestion. The surge in chronic diseases and a growing aging population further bolster this market segment, marking a significant evolution in the delivery of infusion therapies worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Infusion Therapy Market Size by Product & CAGR (2025-2032)

• Market Overview
• Infusion Pumps
  • Ambulatory Infusion Pumps
  • Stationary Infusion Pumps
  • Syringe Infusion Pumps
  • Disposable Pumps
  • Large Volume Pumps
  • Elastomeric pumps
• Infusion Set
• Accessories

Global Infusion Therapy Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Cancer
• Gastrointestinal Diseases/Disorders
• Congestive Heart Failure
• Rheumatoid Arthritis
• Hemophilia
• Immune Deficiencies
• Others

Global Infusion Therapy Market Size by Therapy & CAGR (2025-2032)

• Market Overview
• Antibiotic/Antiviral
• Anti-coagulation
• Anti-emetics
• Blood Component Stimulating Factor
• Chemotherapy
• Nutrition
• Hydration
• Pain Management

Global Infusion Therapy Market Size by Application & CAGR (2025-2032)

• Market Overview
• Chemotherapy
• Diabetes
• Gastrointestinal Diseases
• Pain management
• Others

Global Infusion Therapy Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Homecare Settings

Global Infusion Therapy Market Size & CAGR (2025-2032)

• North America (Product, Indication, Therapy, Application, End-user)
  • US
  • Canada
• Europe (Product, Indication, Therapy, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Indication, Therapy, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Indication, Therapy, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Indication, Therapy, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Option Care Health Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moog Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JMS Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caesarea Medical Electronics (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareFusion Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Poly Medicure Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convatec Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations